Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results - 09/11/22
Doi : 10.1016/j.cll.2022.09.011
Rebecca Yee, PhD, D(ABMM), Patricia J. Simner, PhD, D(ABMM) ⁎ 
Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Meyer B1-193, 600 North Wolfe Street, Baltimore, MD 21287-7093, USA
∗Corresponding author.
Keywords : Whole genome sequencing (WGS), Targeted NGS, Metagenomic next-generation sequencing (mNGS), Clinical microbiology, Antimicrobial resistance, Predictions
Plan
| This article originally appeared in Advances in Molecular Pathology, Volume 2, Issue 1, November 2019. Disclosure Statement: P.J. Simner reports grants and personal fees from Accelerate Diagnostics, grants from BD Diagnostics, Inc., grants from bioMerieux, Inc., grants from Check-Points Diagnostics, BV, grants from Hardy Diagnostics, personal fees from Roche Diagnostics, personal fees from Opgen Inc, personal fees from CosmosID, outside the submitted work; travel funds from Oxford Nanopore Technologies. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 4
P. 557-572 - décembre 2022 Retour au numéro
Article précédent
- Replacement of Culture with Molecular Testing for Diagnosis Infectious Diseases
- Gerald A. Capraro
- Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications
- Gail H. Vance, Wahab A. Khan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?